SwePub
Tyck till om SwePub Sök här!
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "WFRF:(Nilsson Henrik) "

Sökning: WFRF:(Nilsson Henrik)

  • Resultat 1-10 av 1686
Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
1.
  •  
2.
  • Bergström, Petra, et al. (författare)
  • Association of NFE2L2 and KEAP1 haplotypes with amyotrophic lateral sclerosis.
  • 2014
  • Ingår i: Amyotrophic lateral sclerosis & frontotemporal degeneration. - : Informa UK Limited. - 2167-9223 .- 2167-8421. ; 15:1-2, s. 130-137
  • Tidskriftsartikel (refereegranskat)abstract
    • Amyotrophic lateral sclerosis (ALS) is a degenerative motor neuron syndrome influenced by oxidative stress. The transcription factor Nrf2 and its repressor Keap1 constitute an important defence system in cellular protection against oxidative stress. Here we hypothesize that common genetic variations in the genes NFE2L2 and KEAP1, encoding Nrf2 and Keap1, may influence the risk and phenotype of ALS. Five hundred and twenty-two Swedish patients with sporadic ALS (SALS) and 564 Swedish control subjects were studied. Eight tag SNPs in NFE2L2 and three tag SNPs in KEAP1 were genotyped by allelic discrimination and three functional NFE2L2 promoter SNPs were genotyped by sequencing. One NFE2L2 haplotype (GGGAC) was associated with decreased risk of SALS (OR = 0.62 per allele, p = 0.003) and one haplotype in KEAP1 (CGG) was associated with later SALS onset (+3.4 years per allele, p = 0.015). When stratified by subgroup, one haplotype in NFE2L2, GAGCAGA including three functional promoter SNPs associated with high Nrf2 protein expression, was associated with 4.0 years later disease onset per allele in subgroup ALS (p = 0.008). In conclusion, these results suggest that variations in NFE2L2 and KEAP1, encoding two central proteins in cellular oxidative stress defence, may influence SALS pathogenesis.
  •  
3.
  • Einarsdottir, Berglind Osk, 1979, et al. (författare)
  • Melanoma patient-derived xenografts accurately model the disease and develop fast enough to guide treatment decisions.
  • 2014
  • Ingår i: Oncotarget. - : Impact Journals, LLC. - 1949-2553. ; 5:20, s. 9609-18
  • Tidskriftsartikel (refereegranskat)abstract
    • The development of novel therapies against melanoma would benefit from individualized tumor models to ensure the rapid and accurate identification of biomarkers of therapy response. Previous studies have suggested that patient-derived xenografts (PDXes) could be useful. However, the utility of PDXes in guiding real-time treatment decisions has only been reported in anecdotal forms. Here tumor biopsies from patients with stage III and IV metastatic malignant melanoma were transplanted into immunocompromised mice to generate PDXes. 23/26 melanoma biopsies generated serially transplantable PDX models, and their histology, mutation status and expression profile resembled their corresponding patient biopsy. The potential treatment for one patient was revealed by an in vitro drug screen and treating PDXes with the MEK inhibitor trametinib. In another patient, the BRAF mutation predicted the response of both the patient and its corresponding PDXes to MAPK-targeted therapy. Importantly, in this unselected group of patients, the time from biopsy for generation of PDXes until death was significantly longer than the time required to reach the treatment phase of the PDXes. Thus, it could be clinically meaningful to use this type of platform for melanoma patients as a pre-selection tool in clinical trials.
  •  
4.
  • Forsberg, Elin, et al. (författare)
  • HER2 CAR-T Cells Eradicate Uveal Melanoma and T-cell Therapy-Resistant Human Melanoma in IL2 Transgenic NOD/SCID IL2 Receptor Knockout Mice
  • 2019
  • Ingår i: Cancer Research. - 0008-5472. ; 79:5, s. 899-904
  • Tidskriftsartikel (refereegranskat)abstract
    • Chimeric antigen receptors (CAR) can transmit signals akin to those from activated T-cell receptors when bound to a cell surface target. CAR-expressing T cells against CD19 can cause curative effects in leukemia and lymphoma and is approved for clinical use. However, no CAR-T therapy is currently approved for use in solid tumors. We hypothesize that the resistance of solid tumors to CAR-T can be overcome by similar means as those used to reactivate tumor-infiltrating T lymphocytes (TIL), for example, by cytokines or immune checkpoint blockade. Here we demonstrate that CAR-T cells directed against HER2 can kill uveal and cutaneous melanoma cells in vitro and in vivo. Curative effects in vivo were only observed in xenografts grown in a NOD/SCID IL2 receptor gamma (NOG) knockout mouse strain transgenic for human IL2. The effect was target-specific, as CRISPR/Cas9-mediated disruption of HER2 in the melanoma cells abrogated the killing effect of the CAR-T cells. The CAR-T cells were also able to kill melanoma cells from patients resistant to adoptive T-cell transfer (ACT) of autologous TILs. Thus, CAR-T therapy represents an option for patients that do not respond to immunotherapy with ACT of TIL or immune checkpoint blockade. In addition, our data highlight the use of IL2 transgenic NOG mice as models to prove efficacy of CAR-T-cell products, possibly even in a personalized manner. Significance: These findings demonstrate that a novel humanized mouse model can help clinical translation of CAR-T cells against uveal and cutaneous melanoma that do not respond to TIL therapy or immune checkpoint blockade.
  •  
5.
  • Melke, Jonas, 1971, et al. (författare)
  • A polymorphism in the serotonin receptor 3A (HTR3A) gene and its association with harm avoidance in women.
  • 2003
  • Ingår i: Archives of general psychiatry. - : American Medical Association (AMA). - 0003-990X. ; 60:10, s. 1017-23
  • Tidskriftsartikel (refereegranskat)abstract
    • BACKGROUND: The brain neurotransmitter serotonin is known to affect various aspects of human behavior, including personality traits. Serotonin receptor type 3 is a ligand-gated channel encoded by 2 different subunit genes, HTR3A and HTR3B. A polymorphism (C178T) in the 5' region of the HTR3A gene has recently been identified and suggested to be of functional importance. OBJECTIVE: To elucidate the possible association between the C178T polymorphism in the HTR3A gene and personality traits in women. DESIGN: Two independent samples of 35- to 45-year-old Swedish women were recruited using the population register. Sample 1 (n = 195) was assessed via the Karolinska Scales of Personality and the Temperament and Character Inventory; sample 2 (n = 175) was assessed using the latter only. Both samples were genotyped with respect to the C178T polymorphism in the HTR3A gene. The A1596G polymorphism in the same gene was also investigated. RESULTS: A significant association between C178T genotype and the Temperament and Character Inventory factor harm avoidance was observed in sample 1 (corrected for multiple comparisons P =.04); this finding was subsequently replicated in sample 2 (P =.004) (pooled populations: P<.001). In the pooled sample, all harm avoidance subscales were found to be significantly associated with the C178T polymorphism: anticipatory worry (P =.001), fear of uncertainty (P<.001), shyness (P<.001), and fatigability and asthenia (P =.008). In addition, a significant association was found in sample 1 between the C178T polymorphism and the Karolinska Scales of Personality nonconformity factor (corrected P =.002), including the subscales of social desirability (P<.001), indirect aggression (P =.002), verbal aggression (P =.05), and irritability (P<.001). Participants homozygous for the less common T allele (<4%) differed from the remaining women by displaying lower ratings on harm avoidance and nonconformity. CONCLUSION: The C178T polymorphism in the HTR3A gene may affect the personality trait of harm avoidance in women.
  •  
6.
  • Nilsson, Magnus, et al. (författare)
  • A 9-band WCDMA/EDGE transceiver supporting HSPA evolution
  • 2011
  • Ingår i: [Host publication title missing]. - 0193-6530. ; , s. 366-368
  • Konferensbidrag (refereegranskat)abstract
    • The future of cellular radio ICs lies in the integration of an ever-increasing number of bands and channel bandwidths. This paper presents a transceiver together with the associated discrete front-end components. The transceiver supports 4 EDGE bands and 9 WCDMA bands (l-VI and Vlll-X), while the radio can be configured to simultaneously support the 4 EDGE bands and up to 5 WCDMA bands: 3 high bands (HB) and 2 low bands (LB). The RX is a SAW-less homodyne composed of a main RX and a diversity RX. To reduce package complexity with so many bands, we chose to minimize the number of ports by using single-ended RF interfaces for both RX and TX. This saves seve ral package pins, but requires careful attention to grounding. The main RX has 8 LNA ports and the diversity RX has 5, with some LNAs supporting multiple bands. On the TX side, 2 ports are used for all EDGE bands and 4 for the WCDMA bands.
  •  
7.
  • Spotorno, Nicola, et al. (författare)
  • Plasma neurofilament light protein correlates with diffusion tensor imaging metrics in frontotemporal dementia
  • 2020
  • Ingår i: Plos One. - : Public Library of Science (PLoS). - 1932-6203. ; 15:10
  • Tidskriftsartikel (refereegranskat)abstract
    • Neurofilaments are structural components of neurons and are particularly abundant in highly myelinated axons. The levels of neurofilament light chain (NfL) in both cerebrospinal fluid (CSF) and plasma have been related to degeneration in several neurodegenerative conditions including frontotemporal dementia (FTD) and NfL is currently considered as the most promising diagnostic and prognostic fluid biomarker in FTD. Although the location and function of filaments in the healthy nervous system suggests a link between increased NfL and white matter degeneration, such a claim has not been fully elucidated in vivo, especially in the context of FTD. The present study provides evidence of an association between the plasma levels of NfL and white matter involvement in behavioral variant FTD (bvFTD) by relating plasma concentration of NfL to diffusion tensor imaging (DTI) metrics in a group of 20 bvFTD patients. The results of both voxel-wise and tract specific analysis showed that increased plasma NfL concentration is associated with a reduction in fractional anisotropy (FA) in a widespread set of white matter tracts including the superior longitudinal fasciculus, the fronto-occipital fasciculus the anterior thalamic radiation and the dorsal cingulum bundle. Plasma NfL concentration also correlated with cortical thinning in a portion of the right medial prefrontal cortex and of the right lateral orbitofrontal cortex. These results support the hypothesis that blood NfL levels reflect the global level of neurodegeneration in bvFTD and help to advance our understanding of the association between this blood biomarker for FTD and the disease process.
  •  
8.
  •  
9.
  •  
10.
  •  
Skapa referenser, mejla, bekava och länka
  • Resultat 1-10 av 1686
Typ av publikation
tidskriftsartikel (1278)
konferensbidrag (164)
rapport (63)
bokkapitel (61)
annan publikation (40)
doktorsavhandling (26)
visa fler...
forskningsöversikt (23)
bok (10)
samlingsverk (redaktörskap) (8)
licentiatavhandling (5)
recension (5)
proceedings (redaktörskap) (2)
konstnärligt arbete (1)
visa färre...
Typ av innehåll
refereegranskat (1382)
övrigt vetenskapligt/konstnärligt (260)
populärvet., debatt m.m. (44)
Författare/redaktör
Arai, Y. (167)
Alonso, A. (158)
Chen, L (157)
Aad, G (157)
Abbott, B. (157)
Abdinov, O (157)
visa fler...
Zwalinski, L. (157)
Gregersen, K. (157)
Poettgen, R. (157)
Aben, R. (157)
Abreu, H. (157)
Adye, T. (157)
Ahmadov, F. (157)
Aielli, G. (157)
Albrand, S. (157)
Aleksa, M. (157)
Aleksandrov, I. N. (157)
Alexander, G. (157)
Alexopoulos, T. (157)
Alhroob, M. (157)
Alimonti, G. (157)
Alio, L. (157)
Alonso, F. (157)
Alpigiani, C. (157)
Altheimer, A. (157)
Amako, K. (157)
Amelung, C. (157)
Amorim, A. (157)
Amoroso, S. (157)
Amram, N. (157)
Amundsen, G. (157)
Anastopoulos, C. (157)
Ancu, L. S. (157)
Andari, N. (157)
Andeen, T. (157)
Anders, G. (157)
Anderson, K. J. (157)
Andreazza, A. (157)
Angerami, A. (157)
Anghinolfi, F. (157)
Anjos, N. (157)
Annovi, A. (157)
Antonelli, M. (157)
Antonov, A. (157)
Anulli, F. (157)
Aoki, M. (157)
Arabidze, G. (157)
Argyropoulos, S. (157)
Arnaez, O. (157)
Arslan, O. (157)
visa färre...
Lärosäte
Lunds universitet (706)
Göteborgs universitet (440)
Uppsala universitet (388)
Kungliga Tekniska Högskolan (259)
Stockholms universitet (242)
Chalmers tekniska högskola (156)
visa fler...
Karolinska Institutet (137)
Linköpings universitet (113)
Umeå universitet (72)
Sveriges Lantbruksuniversitet (58)
Mittuniversitetet (54)
Handelshögskolan i Stockholm (50)
Malmö universitet (31)
Linnéuniversitetet (27)
Örebro universitet (25)
RISE (21)
Karlstads universitet (19)
Högskolan Väst (10)
Luleå tekniska universitet (9)
Naturhistoriska riksmuseet (8)
Högskolan i Halmstad (6)
Mälardalens universitet (6)
Jönköping University (6)
Högskolan i Borås (6)
Röda Korsets Högskola (6)
Högskolan Kristianstad (5)
Naturvårdsverket (5)
Högskolan i Skövde (5)
Högskolan Dalarna (5)
VTI - Statens väg- och transportforskningsinstitut (5)
IVL Svenska Miljöinstitutet (3)
Södertörns högskola (2)
Blekinge Tekniska Högskola (2)
Högskolan i Gävle (1)
Gymnastik- och idrottshögskolan (1)
Försvarshögskolan (1)
Kungl. Musikhögskolan (1)
visa färre...
Språk
Engelska (1536)
Svenska (138)
Odefinierat språk (11)
Danska (1)
Forskningsämne (UKÄ/SCB)
Naturvetenskap (743)
Medicin och hälsovetenskap (481)
Samhällsvetenskap (279)
Teknik (199)
Lantbruksvetenskap (91)
Humaniora (32)

År

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy